PBS makes scripts for juvenile arthritis easier
In a move warmly welcomed by parents and paediatric rheumatologists alike, the Pharmaceutical Benefits Scheme (PBS) is simplifying approvals for prescribing biologics and biosimilars. These
$21.6 Million in Research Grants for Juvenile Arthritis and Childhood Musculoskeletal Conditions
JAFA welcomes the Health Minister’s April 27, 2022 announcement of the largest-ever research funding allocation
JAFA welcomes ground-breaking Parliamentary Report into Childhood Rheumatic Diseases
This ground-breaking Inquiry was instigated by JAFA and conducted by the House of Representatives Standing
Minding Mental Health
JAFA’s sixth online symposium shines a light on the link between chronic childhood conditions and
Chair Victoria Allen to retire and Emily Sheridan to join the JAFA board
Victoria Allen, the inaugural Chair of Juvenile Arthritis Foundation Australia (JAFA) will retire from the
Landmark Hearings: Parliamentary Inquiry into Childhood Rheumatic Diseases
March 8, 2022 saw an historic landmark for Juvenile Arthritis /childhood rheumatic diseases (JA/CRDs) in
$20 million investment in research to drive better health
Since it’s inception JAFA with many parents, grandparents and friends, have actively been advocating the
KidsConnect
JAFA has long been concerned about the social isolation experiences by children with JA that
JAFA Annual Review 2021 – February 2022
The past two years of JAFA’s existence has heralded truly significant milestones for children and
JAFA’s Pre Election Campaign to Change Lives: Stop Pain and Disability in Children with arthritis
JAFA’s Pre Election Campaign to Change Lives: Stop Pain and Disability in Children with Arthritis.